Alzheimer's & Dementia News and Research

Latest Alzheimer's & Dementia News and Research

New compound prevents amyloid formation to fight Alzheimer’s disease

It is known that Alzheimer’s disease is caused by the formation of amyloid plaques and tau tangles in the brain. A novel compound shows promise in preventing amyloid formation, fighting Alzheimer’s disease development.

3 Feb 2020

Regular aerobic exercise could enhance cognitive functions in adults at risk for Alzheimer’s

Individuals at risk for Alzheimer's disease (AD) because of family history or genetic predisposition who engaged in six months of aerobic exercise training improved their brain glucose metabolism and higher-order thinking abilities (e.g., planning and mental flexibility) called executive function; these improvements occurred in conjunction with increased cardiorespiratory fitness.

3 Feb 2020

New noninvasive way to monitor the health of brain cells using an infrared laser

With no way to reliably tell whether an athlete has a concussion, many may be playing with an undiagnosed injury. Likewise, 2 million people die every year because we don't have an early warning when brain cells are dying--and another 4 million experience cognitive disabilities.

3 Feb 2020

Plant flavonols significantly reduce Alzheimer’s risk

A new study published in the journal Neurology in January 2020 concludes that increasing the intake of plant flavonols steeply reduces the risk of Alzheimer’s dementia (AD) by up to a half. In other words, AD could be prevented in many people simply by regularly eating more of foods containing these compounds such as tea, oranges and broccoli.

2 Feb 2020

A collaborative partnership to understand the impact of music therapies on mental health

The Health and Technology District has partnered with Music Heals and SFU on a new research study using advanced neuroscience and functional brain imaging to understand the neuro-physiological impacts of music therapies on improved mental health.

31 Jan 2020

MSU researcher makes strides in discovering new cellular mechanism

A Montana State University biotechnology researcher was part of an international team that recently discovered an internal mechanism which may protect human cells from oxidative damage.

30 Jan 2020

Potential new biomarker for vascular dementia identified

Vascular dementia is caused by a defect on blood flow arrival to the brain, which consequently generates neuronal damage.

30 Jan 2020

Scientists discover small molecule that may slow or stop Parkinson's disease progression

A collaboration between scientists at Rutgers University and Scripps Research led to the discovery of a small molecule that may slow down or stop the progression of Parkinson's disease.

30 Jan 2020

A high flavonol intake could lower the risk for Alzheimer’s dementia

Older people with a high intake of the antioxidant flavanol may be less likely to develop Alzheimer’s dementia, compared with those who have a low intake.

30 Jan 2020

Study opens up strategies for early diagnosis, treatment of diseases linked to chronic inflammation

Claudio Franceschi, a world-renowned scientist, professor at the University of Bologna (Italy) and head of the Research Laboratory for Systems Medicine of Healthy Aging at Lobachevsky University, together with other members of an international research team, has described the mechanisms underlying chronic inflammation and identified several risk factors leading to disease.

29 Jan 2020

High intake of dietary flavonols tied to lower risk of Alzheimer's dementia

People who eat or drink more foods with the antioxidant flavonol, which is found in nearly all fruits and vegetables as well as tea, may be less likely to develop Alzheimer's dementia years later, according to a study published in the January 29, 2020, online issue of Neurology, the medical journal of the American Academy of Neurology.

29 Jan 2020

Buck study uncovers how astrocyte senescence promotes neurodegeneration

Although a link has been established between chronic inflammation and neurodegenerative diseases, there have been many open questions regarding how cellular senescence, a process whereby cells that stop dividing under stress spew out a mix of inflammatory proteins, affects these pathologies.

29 Jan 2020

Portable device to monitor blink reflex receives FDA clearance

EyeStat (blinktbi, Charleston, SC), a portable, lightweight device for measuring the natural blink reflex, received clearance by the U.S. Food and Drug Administration in December 2019.

29 Jan 2020

New way to treat stroke using an already FDA-approved drug shows promise

Stroke is the third leading cause of death and disability in the United States. More than 87 percent are ischemic strokes, caused by obstruction of one or more cerebral arteries. With limited progress in developing treatments, there is a critical need for neuroprotective agents to effectively treat stroke.

29 Jan 2020

New AI tool predicts disease progression and evolution in neurodegenerative disorders

Researchers have found that testing blood using an artificial intelligence algorithm successfully predicted disease progression in neurodegenerative disorders.

28 Jan 2020

AI analysis of blood samples can predict progression of neurodegenerative disease

Evaluating the effectiveness of therapies for neurodegenerative diseases is often difficult because each patient's progression is different.

28 Jan 2020

Exploring link between elevated blood pressure early in life and dementia

Whether elevated blood pressure early in life translates to increased risk of dementia is a question scientists are working to answer.

28 Jan 2020

Mysterious large holes in cells linked with sense of taste, Alzheimer's disease, asthma

Many cells are covered with mysterious large holes, pores that have been associated with the sense of taste as well as Alzheimer's disease, depression, and even asthma. Knowing the structure of these varied holes will help researchers better understand this range of associations and provide a blueprint for developing new therapies.

27 Jan 2020

ISS researchers estimated 680,000 cases of mild cognitive impairment in 2018

In a study published in the Journal of Alzheimer's Disease, ISS researchers estimated about 680,000 cases of mild cognitive impairment (MCI), in a total of 12,730,960 migrants, aged between 60 and 89 years, living in the European Union in 2018.

27 Jan 2020

A microdose lithium formulation could halt signs of Alzheimer's pathology

There remains a controversy in scientific circles today regarding the value of lithium therapy in treating Alzheimer's disease.

24 Jan 2020

Alzheimer's & Dementia News and Research

Latest Alzheimer's & Dementia News and Research

New compound prevents amyloid formation to fight Alzheimer’s disease

Regular aerobic exercise could enhance cognitive functions in adults at risk for Alzheimer’s

New noninvasive way to monitor the health of brain cells using an infrared laser

Plant flavonols significantly reduce Alzheimer’s risk

A collaborative partnership to understand the impact of music therapies on mental health

MSU researcher makes strides in discovering new cellular mechanism

Potential new biomarker for vascular dementia identified

Scientists discover small molecule that may slow or stop Parkinson's disease progression

A high flavonol intake could lower the risk for Alzheimer’s dementia

Study opens up strategies for early diagnosis, treatment of diseases linked to chronic inflammation

High intake of dietary flavonols tied to lower risk of Alzheimer's dementia

Buck study uncovers how astrocyte senescence promotes neurodegeneration

Portable device to monitor blink reflex receives FDA clearance

New way to treat stroke using an already FDA-approved drug shows promise

New AI tool predicts disease progression and evolution in neurodegenerative disorders

AI analysis of blood samples can predict progression of neurodegenerative disease

Exploring link between elevated blood pressure early in life and dementia

Mysterious large holes in cells linked with sense of taste, Alzheimer's disease, asthma

ISS researchers estimated 680,000 cases of mild cognitive impairment in 2018

A microdose lithium formulation could halt signs of Alzheimer's pathology

Innovation in neuroscience drug discovery - eBook eBook

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Alzheimer's & Dementia News and Research

Latest Alzheimer's & Dementia News and Research

Innovation in neuroscience drug discovery - eBook eBook

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Newsletters you may be interested in